PHARMA NEWS

PHARMA NEWS 0 Comments

Reckitt Benckiser restates commitment to clean, healthy Nigeria

  Reckitt Benckiser, (RB), a leading consumer health and hygiene Company has restated its commitment to a clean and healthy Nigeria that will boost the capacity and productivity of the

Winners of Healthcare Access Challenge (Sandoz HACk) emerge

Sandoz, a Novartis Division, has announced  the three winners of the inaugural Healthcare Access Challenge (Sandoz HACk) . The winners, chosen by a panel of judges at the Wired Health 2017  event in

PHARMA NEWS 0 Comments

Novartis launches SMS for Life 2.0 to help improve access to essential medicines

Novartis announced today the launch of an innovative technology-based healthcare program called SMS for Life 2.0 in Kaduna State, Nigeria. The program aims to increase the availability of essential medicines

Bayer introduces OTC back pain device

German multinational pharmaeuutical company has a drug-free, device for fhe management of pain. The device, Aleve Direct Therapy, uses transcutaneous electrical nerve stimulation (TENS), which delivers stimulating pulses to the

PHARMA NEWS 0 Comments

Worldwide switch to bivalent oral polio vaccine begins on Sunday

The trivalent oral polio vaccine has been instrumental in the near-eradication of the disease worldwide, but the vaccine still has some challenges that can be addressed by switching to a

PHARMA NEWS 0 Comments

EC approves subcutaneous route of administration in Sandoz biosimilar, Binocrit

Sandoz, a Novartis division and the global leader in biosimilars, announced today that the European Commission (EC) has approved a type II variation for the addition of a subcutaneous (s.c.)

NEWS 0 Comments

Fidson Pharma rewards Astymin users

… Rolls out cash promo Users of Astymin brand of multivitamin, will now gain financial and nutritional reward through constant use of the multivitamin. Makers of the brand, Fidson Pharmaceuticals

PHARMA NEWS 0 Comments

Merck, Pfizer, Syndax Collaborate to evaluate combination drug for ovarian cancer

Multinational pharmaceutical companies, Merck, Pfizer and Syndax Pharmaceuticals, Inc. have entered into a collaboration agreement to evaluate avelumab, an investigational fully human anti-PD-L1 IgG1 monoclonal antibody, in combination with Syndax’s

PHARMA NEWS 0 Comments

Philips introduces new diagnostic device to prevent childhood pneumonia

Royal Philips has announced the upcoming release of a Children’s Automated Respiration Monitor, aimed to help improve the diagnosis and treatment of pneumonia in low-resource countries, potentially preventing many of

PHARMA NEWS 0 Comments

Merck, UNESCO to Build Research Capacity in Africa

Merck, a leading science and technology company, today launched, in partnership with United Nations Educational, Scientific and Cultural Organization (UNESCO), the first edition of the UNESCO-Merck Africa Research Summit, to

Firm offers free hypertension screening for Abuja residents

A Nigerian pharmaceutical company, Neimeth international pharmaceuticals plc, plans to conduct free hypertension screening for residents of the Federal Capital Territory, Abuja. The exercise will also include distribution of free

PHARMA NEWS 0 Comments

EU approves new drug for locally advanced basal cell cancer

Swiss multinational pharmaceutical company, Novartis announced today that the European Commission has approved its new drug, Odomzo for the treatment of adult patients with locally advanced basal cell carcinoma (cancer)

PHARMA NEWS 0 Comments

GSK, PSN introduce online training for pharmacists

Multinational pharmaceutical giant, GlaxoSmithKline, (GSK) has partnered the Pharmaceutical Society of Nigeria (PSN) to introduce an innovative online training program for pharmacists in the country. The programme, tagged Scientific Course

OPINION

Hard times here for healthcare, says former NMA boss

Immediate past President of Nigerian Medical Association and current Vice President, West Africa region of the Commonwealth Medical Association, Dr. Osahon Enabulele, took a look at Nigeria’s dwindling oil fortunes

  • 1
  • 2